描述
Medroxyprogesterone Acetate Tablets Product Specifications
Parameter | Details |
---|---|
Product Name | Medroxyprogesterone Acetate Tablets (Maifuxin) |
Generic Name | Medroxyprogesterone Acetate (MPA) |
Synonyms | MPA, 17?Hydroxy?6??methyl?progesterone acetate |
CAS Number | 71?58?9 |
Formulation | Oral tablet |
Strength | 2?mg per tablet |
Pack Size | 100 tablets per bottle |
Dosage Form | Oral tablet |
Approval Number | NMPA China: H44021696 |
Product Code | 86900401001258 |
Manufacturer | Guangzhou Kanghe Pharmaceutical Co., Ltd. |
Barcode | 6939840208199 |
Storage | Store at 20–25?°C; protect from moisture and light |
Intended Use | Laboratory research only |
Medroxyprogesterone Acetate Tablets Mechanism of Action
Medroxyprogesterone acetate (MPA) is a synthetic progestin that activates progesterone receptors and suppresses gonadotropin release, inhibiting estradiol production and ovulation. It offers clinical-level progestational activity used widely in hormonal therapy and contraception .
Research Applications & Pharmacology
-
Hormonal & reproductive studies: models of menstrual regulation, endometrial response, and contraception research.
-
Endocrine research: role in estrogen-dominant conditions like endometriosis and HRT protocols.
-
Dosage protocol: typical in vivo models use 1–10?mg/kg orally, depending on species and study endpoints.
Safety Profile & Handling
Common Effects (based on clinical data):
-
Menstrual irregularities (amenorrhea), abdominal pain, headaches
-
Potential weight gain and mood fluctuations
-
Rare: blood clots, liver impairment (women’s health initiative data) zh.wikipedia.org
Handling Guidelines:
-
Use lab gloves and goggles
-
Store per label and inspect tablets for integrity
-
Dispose per pharmaceutical waste protocols
?? Research Use Disclaimer
This product is strictly for laboratory and research applications. It is not authorized for therapeutic, diagnostic, or clinical use. Misuse can pose health hazards and regulatory non-compliance.
评价
目前还没有评价